Alcresta Therapeutics

RELIZORB

Manufacturer:

Alcresta Therapeutics

Name:

RELIZORB

Category:

B Code

HCPCS:

B4105

NDC(s):

62205-0000-20,

Primary Type:

ERT

Route of Administration:

Route Not Applicable

About:

RELIZORB is a ERT drug manufactured by Alcresta Therapeutics and administered via the Route Not Applicable route of administration. The B Code: B4105 is aligned to the drug RELIZORB.

Access Pricing and More By Registering